Asia Pacific Diagnostic Imaging Market to Grow with a CAGR of 6.27% through 2030
Rising geriatric population and chronic disease burden and rising
medical tourism are factors driving the Asia Pacific Diagnostic imaging market in the
forecast period 2026-2030.
According to
TechSci Research report, “Asia Pacific Diagnostic Imaging Market –Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2030”,
the Asia Pacific Diagnostic Imaging Market stood at USD 9.71 Billion in 2024
and is anticipated to grow with a CAGR of 6.27% in the forecast period, 2026-2030.
There is increasing awareness among both healthcare professionals and the
general population regarding the importance of early disease detection.
Campaigns targeting cancer screening, maternal health, and cardiovascular risk
are fueling the uptake of modalities such as mammography, ultrasound, and CT
scans across Asia Pacific. Urbanization and rising income levels are also
playing a role in improving health literacy and the willingness to invest in
preventive diagnostic procedures.
Several
Asia Pacific governments are implementing favourable regulations and
reimbursement policies to increase the affordability and accessibility of
diagnostic imaging services. Programs promoting preventive healthcare and early
diagnosis are indirectly contributing to higher imaging volumes. For instance,
China’s healthcare reforms and India’s Ayushman Bharat initiative aim to extend
healthcare coverage to millions of citizens, supporting wider adoption of
diagnostic imaging across urban and rural areas alike.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Asia Pacific Diagnostic Imaging Market”
Governments
across the Asia Pacific region are investing heavily in healthcare
infrastructure development, particularly in emerging economies such as India,
Indonesia, Vietnam, and the Philippines. New hospital constructions, upgrades
in public health facilities, and the proliferation of private diagnostic
centers are significantly increasing access to imaging services. Public-private
partnerships and foreign direct investment in the healthcare sector are also
helping to improve diagnostic capabilities in underserved areas.
The Asia Pacific
Diagnostic Imaging Market is segmented into Type, Mobility, Source, Application,
end user, country, and company.
Based on its Application,
the Oncology category held the largest share of revenue in 2024, primarily due to the rising incidence
and prevalence of cancer across the region. With countries like China, India,
Japan, and South Korea witnessing a significant increase in cancer cases, there
is an escalating demand for advanced diagnostic imaging solutions to aid in
early detection, accurate diagnosis, staging, and monitoring of various
cancers. Early and precise diagnosis is critical for improving patient
outcomes, which has driven healthcare providers to invest heavily in imaging
technologies specifically tailored for oncology applications. Another key
factor contributing to the Oncology segment's large revenue share is the
growing awareness and emphasis on cancer screening programs in Asia Pacific
countries. Governments and healthcare organizations are increasingly promoting
routine screenings for common cancers such as breast, lung, liver, and
colorectal cancers. These screening initiatives rely heavily on imaging
modalities like MRI, CT, PET, and ultrasound, which are essential for
non-invasive and detailed visualization of tumors. Consequently, the demand for
oncology-specific diagnostic imaging equipment and services has surged,
supporting the market’s revenue growth.
Based on country,
India is expected to grow during the forecast period, due to a combination of economic,
demographic, healthcare infrastructure, and policy-driven factors. The
country’s expanding population, increasing burden of chronic diseases, and
rising awareness of early disease diagnosis are key demand drivers for advanced
imaging technologies such as MRI, CT scans, and ultrasound systems. With
increasing urbanization and lifestyle changes, India has seen a significant
surge in non-communicable diseases (NCDs) like diabetes, hypertension, obesity,
and cancer. These diseases often require regular monitoring and precise
diagnostic interventions, thereby fueling demand for imaging modalities such as
PET-CT, mammography, and echocardiography. According to multiple national
health surveys, the prevalence of NCDs is rising steadily, further solidifying
the need for expanded imaging capacity. India is investing significantly in
upgrading its healthcare infrastructure, including the expansion of hospitals,
diagnostic centers, and medical colleges in both urban and rural regions.
Government initiatives such as Ayushman Bharat (India’s
national health protection scheme) and increased FDI in the healthcare sector
have encouraged private players to set up imaging centers, particularly in
Tier-II and Tier-III cities. This geographic spread is contributing to market
penetration and revenue growth.
Major companies
operating in the Asia Pacific Diagnostic Imaging Market are:
- Wipro GE
Healthcare Pvt. Ltd. (GE Healthcare Limited)
- Siemens
Healthcare Private Limited
- Canon Medical
Systems Corporation
- Hitachi Ltd.
- FUJIFILM
Holdings Corporation
- Mindray Medical
International Ltd.
- Shimadzu
Corporation
- Allengers
Medical Systems Limited
- Hologic Hub
Ltd.
- Koninklijke
Philips N.V.
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The
Asia Pacific diagnostic imaging market is poised for continued expansion,
supported by a favorable confluence of demographic trends, healthcare
investments, technological innovation, and rising awareness. As the region
continues to bridge healthcare access gaps and embrace next-generation imaging
solutions, it is expected to emerge as one of the fastest-growing markets
globally in the diagnostic imaging landscape. Strategic partnerships, local
manufacturing, and AI-enabled solutions will be pivotal in unlocking long-term
market potential,” said Mr. Karan Chechi, Research Director of TechSci
Research, a research-based management consulting firm.
“Asia Pacific Diagnostic imaging Market - By Type (X-Ray Imaging Solutions, Ultrasound
Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions, Mammography,
Others), By Mobility (Portable v/s Standalone), By Source (Domestic Vs Import),
By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology,
Gynecology, Others), By End Users (Hospitals & Clinics, Diagnostic Centers,
Ambulatory Care Centers, Others), By Country, Competition Forecast & Opportunities, 2020-2030F”, has evaluated the future growth
potential of Asia Pacific Diagnostic Imaging Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Asia Pacific Diagnostic Imaging Market.
Contact
TechSci Research
LLC
420 Lexington
Avenue, Suite 300, New York, United
States- 10170
Email: [email protected]
M: +13322586602